Literature DB >> 12952845

Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling.

Francisco J Villarreal1, Michael Griffin, Jeffrey Omens, Wolfgang Dillmann, Judy Nguyen, James Covell.   

Abstract

BACKGROUND: Myocardial infarction (MI) is associated with early metalloproteinase (MMP) activation and extracellular matrix (ECM) degradation. We hypothesized that preserving the original ECM of the infarcted left ventricle (LV) by use of early short-term doxycycline (DOX) treatment preserves cardiac structure and function. METHODS AND
RESULTS: LV morphometry and function were measured in 3 groups of rats (sham, MI, and MI+DOX). DOX (30 mg/kg per day) was given orally 48 hours before and 48 hours after MI. Rats were examined at 2 and 4 weeks after MI. By 4 weeks, DOX significantly decreased (P<0.05 versus MI) the heart weight to body weight ratio, myocyte cross-sectional area, and internal LV diameter, whereas it preserved anterior wall thickness within the infarct. Collagen/muscle area fraction did not change in the region of the infarct/scar. Parallel left shifts (versus MI) were observed in pressure-volume relationships of DOX MI rats at all pressures. DOX treatment also shifted passive epicardial strains within the scar area toward normal values. No differences were observed in LV end-diastolic or peak systolic pressures, peak positive or negative LV dP/dt, or isovolumic relaxation rates. Assessment of LV global MMP and MMP-2/9 activities 1 hour after MI using fluorescent probes yielded significant differences with DOX.
CONCLUSIONS: Brief, early MMP inhibition after MI yields preservation of LV structure and global as well as scar area passive function, supporting the concept that preserving the original ECM early after coronary occlusion lessens ventricular remodeling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12952845     DOI: 10.1161/01.CIR.0000089090.05757.34

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  46 in total

1.  Anisotropic reinforcement of acute anteroapical infarcts improves pump function.

Authors:  Gregory M Fomovsky; Samantha A Clark; Katherine M Parker; Gorav Ailawadi; Jeffrey W Holmes
Journal:  Circ Heart Fail       Date:  2012-06-04       Impact factor: 8.790

2.  Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity.

Authors:  David T Puerta; Michael O Griffin; Jana A Lewis; Diego Romero-Perez; Ricardo Garcia; Francisco J Villarreal; Seth M Cohen
Journal:  J Biol Inorg Chem       Date:  2005-12-03       Impact factor: 3.358

Review 3.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

4.  Aliskiren and valsartan mediate left ventricular remodeling post-myocardial infarction in mice through MMP-9 effects.

Authors:  Trevi A Ramirez; Rugmani Padmanabhan Iyer; Omid Ghasemi; Elizabeth F Lopez; Daniel B Levin; Jianhua Zhang; Rogelio Zamilpa; Youn-Min Chou; Yu-Fang Jin; Merry L Lindsey
Journal:  J Mol Cell Cardiol       Date:  2014-04-23       Impact factor: 5.000

Review 5.  Myocardial matrix metalloproteinase-2: inside out and upside down.

Authors:  Ashley DeCoux; Merry L Lindsey; Francisco Villarreal; Ricardo A Garcia; Richard Schulz
Journal:  J Mol Cell Cardiol       Date:  2014-09-28       Impact factor: 5.000

6.  MT1-MMP-dependent remodeling of cardiac extracellular matrix structure and function following myocardial infarction.

Authors:  Gerald C Koenig; R Grant Rowe; Sharlene M Day; Farideh Sabeh; Jeffrey J Atkinson; Kenneth R Cooke; Stephen J Weiss
Journal:  Am J Pathol       Date:  2012-03-29       Impact factor: 4.307

7.  Loss of dystrophin is associated with increased myocardial stiffness in a model of left ventricular hypertrophy.

Authors:  Martín Donato; Bruno Buchholz; Celina Morales; Laura Valdez; Tamara Zaobornyj; Sergio Baratta; Diamela T Paez; Mirian Matoso; Guillermo Vaccarino; Demian Chejtman; Oscar Agüero; Juan Telayna; José Navia; Alejandro Hita; Alberto Boveris; Ricardo J Gelpi
Journal:  Mol Cell Biochem       Date:  2017-03-18       Impact factor: 3.396

Review 8.  Can heart function lost to disease be regenerated by therapeutic targeting of cardiac scar tissue?

Authors:  Emily L Ongstad; Robert G Gourdie
Journal:  Semin Cell Dev Biol       Date:  2016-05-24       Impact factor: 7.727

Review 9.  Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.

Authors:  Shuaibo Huang; Nikolaos G Frangogiannis
Journal:  Br J Pharmacol       Date:  2018-03-04       Impact factor: 8.739

10.  Inhibition of matrix metalloproteinase-2 by PARP inhibitors.

Authors:  Adrian C Nicolescu; Andrew Holt; Arulmozhi D Kandasamy; Pal Pacher; Richard Schulz
Journal:  Biochem Biophys Res Commun       Date:  2009-07-18       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.